Different roles of host and bacterial factors in Escherichia coli extra-intestinal infections

Clinical Microbiology and Infection

Volumn 15, Issue 4, 2009, Pages 372-379

  Wang, M C ^a   Tseng, C C ^a   Wu, A B ^a   Huang, J J ^a   Sheu, B S ^b   Wu, J J ^a  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

Bacterial virulence; Biliary tract infection; Biofilm; Escherichia coli; Peritonitis; Phylogeny; Urinary tract infection

Indexed keywords

ADHESIN; AMPICILLIN; BACTERIAL PROTEIN; CEFAZOLIN; CEFEPIME; CEFIXIME; CEFMETAZOLE; CEFOTAXIME; CEFOXITIN; CEFPIROME; CEFPODOXIME; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; GENTAMICIN; LEVOFLOXACIN; LOMEFLOXACIN; PROTEIN AFA; PROTEIN FIMH; PROTEIN FOC; PROTEIN IHA; PROTEIN OMPT; PROTEIN PAPG I; PROTEIN PAPG II; PROTEIN PAPG III; PROTEIN SFA; QUINOLINE DERIVED ANTIINFECTIVE AGENT; UNCLASSIFIED DRUG;

ACUTE APPENDICITIS; ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL IMMUNITY; BACTERIAL INFECTION; BACTERIAL PERITONITIS; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; BACTERIURIA; BILIARY TRACT INFECTION; BIOFILM; CONTROLLED STUDY; DIGESTIVE SYSTEM PERFORATION; ESCHERICHIA COLI; FEMALE; HOST PATHOGEN INTERACTION; HOST RESISTANCE; HUMAN; IMMUNOCOMPETENCE; INFECTION SENSITIVITY; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PHYLOGENY; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; URINARY TRACT INFECTION;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI;

EID: 65449188290     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2009.02708.x     Document Type: Article

References (42)

1. Johnson JR, Scheutz F, Ulleryd P, Kuskowski MA, O'Bryan TT, Sandberg T. Host-pathogen relationships among Escherichia coli isolates recovered from men with febrile urinary tract infection. Clin Infect Dis 2005; 40: 813-822.
2. Johnson JR, Kuskowski MA, O'Bryan TT, Maslow JN. Epidemiological correlates of virulence genotype and phylogenetic background among Escherichia coli blood isolates from adults with diverse-source bacteremia. J Infect Dis 2002; 185: 1439-1447.
3. Wang MC, Tseng CC, Chen CY, Wu JJ, Huang JJ. The role of bacterial virulence and host factors in patients with Escherichia coli bacteremia who have acute cholangitis or upper urinary tract infection. Clin Infect Dis 2002; 35: 1161-1166.
4. Reisner A, Krogfelt KA, Klein BM, Zechner EL, Molin S. In vitro biofilm formation of commensal and pathogenic Escherichia coli strains: Impact of environmental and genetic factors. J Bacteriol 2006; 188: 3572-3581.
5. Gupta K, Hooton TM, Stamm WE. Increasing antimicrobial resistance and the management of uncomplicated community-acquired urinary tract infections. Ann Intern Med 2001; 135: 41-50.
6. Herzer PJ, Inouye S, Inouye M, Whittam TS. Phylogenetic distribution of branched RNA-linked multicopy single-stranded DNA among natural isolates of Escherichia coli. J Bacteriol 1990; 172: 6175-6181.
7. Goullet P, Picard B. Highly pathogenic strains of Escherichia coli revealed by the electrophoretic patterns of carboxylesterase B. J Gen Microbiol 1986; 132: 1853-1858.
8. Johnson JR, Stell AL. Extended virulence genotypes of Escherichia coli strains from patients with urosepsis in relation to phylogeny and host compromise. J Infect Dis 2000; 181: 261-272.
9. Picard B, Garcia JS, Gouriou S et al. The link between phylogeny and virulence in Escherichia coli extraintestinal infection. Infect Immun 1999; 67: 546-553.
10. Bingen-Bidois M, Clermont O, Bonacorsi S et al. Phylogenetic analysis and prevalence of urosepsis strains of Escherichia coli bearing pathogenicity island-like domains. Infect Immun 2002; 70: 3216-3226.
11. Johnson JR. Virulence factors in Escherichia coli urinary tract infection. Clin Microbiol Rev 1991; 4: 80-128.
12. Donnenberg MS, Welch RA. Virulence determinants of uropathogenic Escherichia coli. In: Mobley HLT, Warren JW, eds, Urinary tract infections: Molecular pathogenesis and clinical management. Washington, DC: ASM Press, 1996; 135-174.
13. Johnson JR, Russo TA. Extraintestinal pathogenic Escherichia coli: 'the other bad E. coli'. J Lab Clin Med 2002; 139: 155-162.
14. Parsek MR, Singh PK. Bacterial biofilms: An emerging link to disease pathogenesis. Annu Rev Microbiol 2003; 57: 677-701.
15. Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: A common cause of persistent infections. Science 1999; 284: 1318-1322.
16. Soto SM, Smithson A, Horcajada JP, Martinez JA, Mensa JP, Vila J. Implication of biofilm formation in the persistence of urinary tract infection caused by uropathogenic Escherichia coli. Clin Microbiol Infect 2006; 12: 1034-1036.
17. Wu CJ, Lee HC, Lee NY et al. Predominance of Gram-negative bacilli and increasing antimicrobial resistance in nosocomial bloodstream infections at a university hospital in southern Taiwan, 1996-2003. J Microbiol Immunol Infect 2006; 39: 135-143.
18. Hsueh PR, Chen WH, Luh KT. Relationships between antimicrobial use and antimicrobial resistance in Gram-negative bacteria causing nosocomial infections from 1991-2003 at a university hospital in Taiwan. Int J Antimicrob Agents 2005; 26: 463-472.
19. Diekema DJ, BootsMiller BJ, Vaughn TE et al. Antimicrobial resistance trends and outbreak frequency in United States hospitals. Clin Infect Dis 2004; 38: 78-85.
20. Johnson JR, Kuskowski MA, Gajewski A, Sahm DF, Karlowsky JA. Virulence characteristics and phylogenetic background of multidrug-resistant and antimicrobial-susceptible clinical isolates of Escherichia coli from across the United States, 2000-2001. J Infect Dis 2004; 190: 1739-1744.
21. Martinez JA, Soto S, Fabrega A et al. Relationship of phylogenetic background, biofilm production, and time to detection of growth in blood culture vials with clinical variables and prognosis associated with Escherichia coli bacteremia. J Clin Microbiol 2006; 44: 1468-1474.
22. Ferraro MJ, Gilligan PH, Saubolle MA, Weissfeld AS. Bacteriology. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, eds, Manual of clinical microbiology, 6th edn. Washington, DC: American Society for Microbiology, 1995; 246-262.
23. Clermont O, Bonacorsi S, Bingen E. Rapid and simple determination of the Escherichia coli phylogenetic group. Appl Environ Microbiol 2000; 66: 4555-4558.
24. Tseng CC, Wu JJ, Liu HL, Sung JM, Huang JJ. Roles of host and bacterial virulence factors in the development of upper urinary tract infection caused by Escherichia coli. Am J Kidney Dis 2002; 39: 744-752.
25. Kanamaru S, Kurazono H, Ishitoya S et al. Distribution and genetic association of putative uropathogenic virulence factors iroN, iha, kpsMT, ompT and usp in Escherichia coli isolated from urinary tract infections in Japan. J Urol 2003; 170: 2490-2493.
26. Johnson JR, Stapleton AE, Russo TA, Scheutz F, Brown JJ, Maslow JN. Characteristics and prevalence within serogroup. O4 of a J96-like clonal group of uropathogenic Escherichia coli O4:H5 containing the class I and class III alleles of papG. Infect Immun 1997; 65: 2153-2159.
27. Mitsumori K, Terai A, Yamamoto S, Yoshida O. Identification of S, F1C and three PapG fimbrial adhesins in uropathogenic Escherichia coli by polymerase chain reaction. FEMS Immunol Med Microbiol 1998; 21: 261-268.
28. Blanco M, Blanco JE, Alonso MP et al. Detection of pap, sfa and afa adhesin-encoding operons in uropathogenic Escherichia coli strains: relationship with expression of adhesins and production of toxins. Res Microbiol 1997; 148: 745-755.
29. Wakimoto N, Nishi J, Sheikh J et al. Quantitative biofilm assay using a microtiter plate to screen for enteroaggregative Escherichia coli. Am J Trop Med Hyg 2004; 71: 687-690.
30. Kanamaru S, Kurazono H, Terai A et al. Increased biofilm formation in Escherichia coli isolated from acute prostatitis. Int J Antimicrob Agents 2006; 28 (suppl 1): S21-S25.
31. Jackson DW, Suzuki K, Oakford L, Simecka JW, Hart ME, Romeo T. Biofilm formation and dispersal under the influence of the global regulator CsrA of Escherichia coli. J Bacteriol 2002; 184: 290-301.
32. Narisawa N, Furukawa S, Ogihara H, Yamasaki M. Estimation of the biofilm formation of Escherichia coli K-12 by the cell number. J Biosci Bioeng 2005; 99: 78-80.
33. Duriez P, Clermont O, Bonacorsi S et al. Commensal Escherichia coli isolates are phylogenetically distributed among geographically distinct human populations. Microbiology 2001; 147: 1671-1676.
34. Johnson JR, Owens K, Gajewski A, Kuskowski MA. Bacterial characteristics in relation to clinical source of Escherichia coli isolates from women with acute cystitis or pyelonephritis and uninfected women. J Clin Microbiol 2005; 43: 6064-6072.
35. Wiselka MF. Bacterial and host factors in the pathogenesis of urinary tract infections. In: Cattell WR, ed, Infections of the kidney and urinary tract. New York: Oxford, 1996; 8-33.
36. Sung JY, Costerton JW, Shaffer EA. Defense system in the biliary tract against bacterial infection. Dig Dis Sci 1992; 37: 689-696.
37. Maluenda F, Csendes A, Burdiles P, Diaz J. Bacteriological study of choledochal bile in patients with common bile duct stones, with or without acute suppurative cholangitis. Hepatogastroenterology 1989; 36: 132-135.
38. Chetlin SH, Elliott DW. Biliary bacteremia. Arch Surg 1971; 102: 303-307.
39. Such J, Runyon BA. Spontaneous bacterial peritonitis. Clin Infect Dis 1998; 27: 669-674.
40. Evans LT, Kim WR, Poterucha JJ, Kamath PS. Spontaneous bacterial peritonitis in asymptomatic outpatients with cirrhotic ascites. Hepatology 2003; 37: 897-901.
41. Otto G, Sandberg T, Marklund BI, Ulleryd P, Svanborg C. Virulence factors and pap genotype in Escherichia coli isolates from women with acute pyelonephritis, with or without bacteremia. Clin Infect Dis 1996; 17: 448-456.
42. Tseng CC, Huang JJ, Ko WC, Yan JJ, Wu JJ. Decreased predominance of papG class II allele in Escherichia coli strains isolated from adults with acute pyelonephritis and urinary tract abnormalities. J Urol 2001; 166: 1643-1646.